Literature DB >> 33599485

Identification of Cryptic Binding Sites Using MixMD with Standard and Accelerated Molecular Dynamics.

Richard D Smith1, Heather A Carlson1.   

Abstract

Protein dynamics play an important role in small molecule binding and can pose a significant challenge in the identification of potential binding sites. Cryptic binding sites have been defined as sites which require significant rearrangement of the protein structure to become physically accessible to a ligand. Mixed-solvent MD (MixMD) is a computational protocol which maps the surface of the protein using molecular dynamics (MD) of the unbound protein solvated in a 5% box of probe molecules with explicit water. This method has successfully identified known active and allosteric sites which did not require reorganization. In this study, we apply the MixMD protocol to identify known cryptic sites of 12 proteins characterized by a wide range of conformational changes. Of these 12 proteins, three require reorganization of side chains, five require loop movements, and four require movement of more significant structures such as whole helices. In five cases, we find that standard MixMD simulations are able to map the cryptic binding sites with at least one probe type. In two cases (guanylate kinase and TIE-2), accelerated MD, which increases sampling of torsional angles, was necessary to achieve mapping of portions of the cryptic binding site missed by standard MixMD. For more complex systems where movement of a helix or domain is necessary, MixMD was unable to map the binding site even with accelerated dynamics, possibly due to the limited timescale (100 ns for individual simulations). In general, similar conformational dynamics are observed in water-only simulations and those with probe molecules. This could imply that the probes are not driving opening events but rather take advantage of mapping sites that spontaneously open as part of their inherent conformational behavior. Finally, we show that docking to an ensemble of conformations from the standard MixMD simulations performs better than docking the apo crystal structure in nine cases and even better than half of the bound crystal structures. Poorer performance was seen in docking to ensembles of conformations from the accelerated MixMD simulations.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33599485      PMCID: PMC8091066          DOI: 10.1021/acs.jcim.0c01002

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  75 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Are induced fit protein conformational changes caused by ligand-binding predictable? A molecular dynamics investigation.

Authors:  Cen Gao; Jeremy Desaphy; Michal Vieth
Journal:  J Comput Chem       Date:  2017-04-16       Impact factor: 3.376

3.  X-ray crystallographic studies of serotonin N-acetyltransferase catalysis and inhibition.

Authors:  Eva Wolf; Jacqueline De Angelis; Ehab M Khalil; Philip A Cole; Stephen K Burley
Journal:  J Mol Biol       Date:  2002-03-22       Impact factor: 5.469

Review 4.  Investigating Cryptic Binding Sites by Molecular Dynamics Simulations.

Authors:  Antonija Kuzmanic; Gregory R Bowman; Jordi Juarez-Jimenez; Julien Michel; Francesco L Gervasio
Journal:  Acc Chem Res       Date:  2020-03-05       Impact factor: 22.384

5.  Reproducing crystal binding modes of ligand functional groups using Site-Identification by Ligand Competitive Saturation (SILCS) simulations.

Authors:  E Prabhu Raman; Wenbo Yu; Olgun Guvench; Alexander D Mackerell
Journal:  J Chem Inf Model       Date:  2011-04-01       Impact factor: 4.956

6.  Full protein flexibility is essential for proper hot-spot mapping.

Authors:  Katrina W Lexa; Heather A Carlson
Journal:  J Am Chem Soc       Date:  2010-12-15       Impact factor: 15.419

7.  Structure-based identification of a ricin inhibitor.

Authors:  X Yan; T Hollis; M Svinth; P Day; A F Monzingo; G W Milne; J D Robertus
Journal:  J Mol Biol       Date:  1997-03-14       Impact factor: 5.469

8.  CSAR 2014: A Benchmark Exercise Using Unpublished Data from Pharma.

Authors:  Heather A Carlson; Richard D Smith; Kelly L Damm-Ganamet; Jeanne A Stuckey; Aqeel Ahmed; Maire A Convery; Donald O Somers; Michael Kranz; Patricia A Elkins; Guanglei Cui; Catherine E Peishoff; Millard H Lambert; James B Dunbar
Journal:  J Chem Inf Model       Date:  2016-05-17       Impact factor: 4.956

9.  Refined structure of the complex between guanylate kinase and its substrate GMP at 2.0 A resolution.

Authors:  T Stehle; G E Schulz
Journal:  J Mol Biol       Date:  1992-04-20       Impact factor: 5.469

10.  Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies.

Authors:  Jeffrey R Huth; Chang Park; Andrew M Petros; Aaron R Kunzer; Michael D Wendt; Xilu Wang; Christopher L Lynch; Jamey C Mack; Kerry M Swift; Russell A Judge; Jun Chen; Paul L Richardson; Sha Jin; Stephen K Tahir; Edward D Matayoshi; Sarah A Dorwin; Uri S Ladror; Jean M Severin; Karl A Walter; Diane M Bartley; Stephen W Fesik; Steven W Elmore; Philip J Hajduk
Journal:  Chem Biol Drug Des       Date:  2007-07       Impact factor: 2.817

View more
  4 in total

1.  Application of Site-Identification by Ligand Competitive Saturation in Computer-Aided Drug Design.

Authors:  Himanshu Goel; Anthony Hazel; Wenbo Yu; Sunhwan Jo; Alexander D MacKerell
Journal:  New J Chem       Date:  2021-11-29       Impact factor: 3.591

Review 2.  Enhanced sampling without borders: on global biasing functions and how to reweight them.

Authors:  Anna S Kamenik; Stephanie M Linker; Sereina Riniker
Journal:  Phys Chem Chem Phys       Date:  2022-01-19       Impact factor: 3.676

3.  A pocket-based 3D molecule generative model fueled by experimental electron density.

Authors:  Lvwei Wang; Rong Bai; Xiaoxuan Shi; Wei Zhang; Yinuo Cui; Xiaoman Wang; Cheng Wang; Haoyu Chang; Yingsheng Zhang; Jielong Zhou; Wei Peng; Wenbiao Zhou; Bo Huang
Journal:  Sci Rep       Date:  2022-09-06       Impact factor: 4.996

4.  Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability.

Authors:  Yue Qiu; Qing Liu; Gao Tu; Xiao-Jun Yao
Journal:  Int J Mol Sci       Date:  2022-09-24       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.